Exact Sciences Corporation (EXAS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
16.73-2.86 (-14.60%)
At close: 4:00 PM EDT

16.76 0.03 (0.18%)
After hours: 6:31 PM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close19.59
Bid16.80 x 300
Ask16.99 x 1000
Day's Range16.26 - 18.89
52wk Range4.67 - 22.80
1y Target EstN/A
Market Cap1.81B
P/E Ratio (ttm)-9.22
Avg Vol (3m)3,618,890
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Here's Why Exact Sciences Corporation's Stock Is Dropping Today
    Motley Fool6 hours ago

    Here's Why Exact Sciences Corporation's Stock Is Dropping Today

    Shares plunge after management reins in its full-year revenue guidance range after reporting a blowout quarter.

  • American City Business Journals8 hours ago

    Exact Sciences' 3Q loss narrows as product use soars

    Exact Sciences Corp. said Wednesday that its net loss narrowed in the third quarter as heavy marketing continued to boost sales of its flagship Cologuard cancer screening product. Madison-based Exact Sciences (EXAS) reported a net loss of $37.8 million, or 36 cents per share, compared with a net loss of $42.9 million, or 45 cents per share, for the same period a year ago. Exact Sciences is a molecular diagnostics company that has developed a noninvasive DNA-based test to detect colorectal cancer.

  • Associated Press13 hours ago

    Exact Sciences reports 3Q loss

    The Madison, Wisconsin-based company said it had a loss of 36 cents per share. The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ...